Linden Thomas Advisory Services, LLC Blueprint Medicines Corp Transaction History

Linden Thomas Advisory Services, LLC

  • $732 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023
BUY
$42.2 - $66.37 $12,364 - $19,446
293 Added 1.73%
17,212 $1.09 Billion
Q1 2023

Apr 24, 2023
BUY
$37.97 - $50.0 $38,767 - $51,050
1,021 Added 6.42%
16,919 $761 Million
Q4 2022

Feb 16, 2023
BUY
$41.06 - $66.48 $652,771 - $1.06 Million
15,898 New
15,898 $696 Million

Others Institutions Holding BPMC

# of Institutions
351
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Linden Thomas Advisory Services, LLC Portfolio

Follow Linden Thomas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Linden Thomas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Linden Thomas Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email